NCT03450044View on ClinicalTrials.gov

Immunogenicity and Safety of DCs in Breast Cancer

PHASE1/PHASE2CompletedINTERVENTIONAL
Enrollment

15

Participants

Timeline

Start Date

January 31, 2014

Primary Completion Date

July 31, 2018

Study Completion Date

August 31, 2018

Conditions
Breast Cancer Female
Interventions
BIOLOGICAL

Dendritic cells

Adoptive transfer of autologous DCs

Trial Locations (1)

111321

Fundación Salud de los Andes, Bogota

All Listed Sponsors
collaborator

Universidad Nacional de Colombia

OTHER

collaborator

Instituto Colombiano para el Desarrollo de la Ciencia y la Tecnología (COLCIENCIAS)

OTHER_GOV

lead

Fundación Salud de los Andes

OTHER

NCT03450044 - Immunogenicity and Safety of DCs in Breast Cancer | Biotech Hunter | Biotech Hunter